BEVACIZUMAB for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for Prophylaxis.
Most Reported Side Effects for BEVACIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,094 | 15.5% | 3,560 | 1,814 |
| Death | 8,493 | 10.9% | 8,485 | 726 |
| Diarrhoea | 4,911 | 6.3% | 1,110 | 1,932 |
| Disease progression | 4,653 | 6.0% | 1,838 | 749 |
| Fatigue | 4,572 | 5.9% | 1,358 | 1,294 |
| Nausea | 4,357 | 5.6% | 1,050 | 1,459 |
| Hypertension | 4,309 | 5.5% | 534 | 1,181 |
| Anaemia | 3,221 | 4.1% | 587 | 1,289 |
| Vomiting | 3,193 | 4.1% | 794 | 1,404 |
| Neutropenia | 2,875 | 3.7% | 449 | 720 |
| Pyrexia | 2,602 | 3.3% | 512 | 1,618 |
| Decreased appetite | 2,559 | 3.3% | 682 | 944 |
| Asthenia | 2,489 | 3.2% | 790 | 924 |
| Drug ineffective | 2,488 | 3.2% | 493 | 369 |
| Proteinuria | 2,384 | 3.1% | 325 | 459 |
Other Indications for BEVACIZUMAB
Product used for unknown indication (9,041)
Hepatocellular carcinoma (7,773)
Colorectal cancer metastatic (5,474)
Ovarian cancer (5,283)
Non-small cell lung cancer (4,136)
Colon cancer (4,015)
Colorectal cancer (2,788)
Breast cancer (2,130)
Lung neoplasm malignant (1,810)
Glioblastoma (1,610)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)